These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11698987)

  • 21. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
    Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
    Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
    Tang S; Ho SK; Moniri K; Lai KN; Chan TM
    Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
    Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
    Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Levy V; Grant RM
    Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment.
    Aghasadeghi MR; Bahramali G; Sadat SM; Farahani A; Mohraz M; Davar Siadat S; Mostafavi E; Memarnejadian A; Ardestani MS; Vahabpour R; Saraji AA; Delbaz SA
    Curr HIV Res; 2011 Jun; 9(4):263-9. PubMed ID: 21671883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
    Günther S; von Breunig F; Santantonio T; Jung MC; Gaeta GB; Fischer L; Sterneck M; Will H
    J Hepatol; 1999 May; 30(5):749-54. PubMed ID: 10365797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
    Gu L; Han Y; Li Y; Zhu T; Song X; Huang Y; Yang F; Guan S; Xie J; Gohda J; Hosoya N; Kawana-Tachikawa A; Liu W; Gao GF; Iwamoto A; Li T; Ishida T
    PLoS One; 2015; 10(8):e0134539. PubMed ID: 26288093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
    Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
    Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.
    Thibault V; Benhamou Y; Seguret C; Bochet M; Katlama C; Bricaire F; Opolon P; Poynard T; Agut H
    J Clin Microbiol; 1999 Sep; 37(9):3013-6. PubMed ID: 10449493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
    Lau GK; Tsiang M; Hou J; Yuen S; Carman WF; Zhang L; Gibbs CS; Lam S
    Hepatology; 2000 Aug; 32(2):394-9. PubMed ID: 10915748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy.
    Thio CL
    Antivir Ther; 2010; 15(3 Pt B):487-91. PubMed ID: 20516569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
    Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
    Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
    Wang HF; Li L; Su HB; Ji W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.